What Researchers Did
This study investigated the relationship between the timing of hyperbaric oxygen therapy (HBOT) after carbon monoxide exposure and the development of delayed neurological problems in 167 patients.
What They Found
Researchers found that patients with a Glasgow Coma Scale (GCS) score of 9 or less had a 5.059 times higher chance of developing delayed neurological sequelae (DNS). Crucially, patients who received HBOT 200 minutes or more after carbon monoxide exposure had an 18.971 times higher chance of developing DNS, suggesting that quicker treatment may be beneficial.
What This Means for Canadian Patients
For Canadian patients experiencing carbon monoxide poisoning, these findings highlight the potential importance of receiving hyperbaric oxygen therapy as quickly as possible to reduce the risk of long-term neurological issues. Early assessment of consciousness levels, such as the GCS score, could also help identify patients at higher risk for developing these delayed problems.
Canadian Relevance
Carbon monoxide poisoning is a Health Canada-recognized indication for hyperbaric oxygen therapy. While this study was not conducted in Canada, its findings are relevant to Canadian healthcare practices for managing this condition.
Study Limitations
The study was conducted at a single hospital, which may limit how broadly its findings can be applied to other patient populations.